特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

噴霧式経鼻ワクチンの世界市場レポート:実績と予測 (2015-2026年) - メーカー・主要地域・アプリケーション別の内訳データ

Global Nasal Spray Vaccine Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions and Application

発行 QYResearch 商品コード 950313
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。
噴霧式経鼻ワクチンの世界市場レポート:実績と予測 (2015-2026年) - メーカー・主要地域・アプリケーション別の内訳データ Global Nasal Spray Vaccine Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions and Application
出版日: 2020年07月17日 ページ情報: 英文 114 Pages
概要

世界における噴霧式経鼻ワクチン市場の規模は、2019年の1億1496万米ドルから、2026年末までに1億9826万米ドルへ達すると予測され、2020年から2026年にかけては7.66%のCAGRで推移すると見込まれています。

当レポートは、噴霧式経鼻ワクチン市場について調査し、各セグメント・地域別による市場規模、世界市場の競合情勢などについて分析しています。

第1章 噴霧式経鼻ワクチン市場の概要

  • 製品概要
  • インフルエンザ予防接種とFluMist/フルミスト (弱毒生インフルエンザワクチン) の違い
  • 新型コロナウイルス感染症(Covid-19)は世界の成長に深刻な影響を与える
    • Covid-19の影響: 世界のGDP成長
    • Covid-19の影響:商品価格指数
    • Covid-19の影響: 世界の主要政府政策

第2章 世界の噴霧式経鼻ワクチン市況・展望:地域別

  • 世界市場規模・CAGR:地域別
  • 世界市場シェア:地域別
    • 世界市場の売上シェア:地域別
    • 世界市場の収益シェア:地域別
  • 世界市場シェア予測:地域別
    • 世界市場の売上シェア予測:地域別
    • 世界市場の収益シェア予測:地域別
  • 北米の市場規模・前年比成長率
    • 収益の前年比成長率
    • 売上の前年比成長率
  • アジア太平洋の市場規模・前年比成長率
    • 収益の前年比成長率
    • 売上の前年比成長率
  • 欧州の市場規模・前年比成長率
    • 収益の前年比成長率
    • 売上の前年比成長率
  • 南米の市場規模・前年比成長率
    • 収益の前年比成長率
    • 売上の前年比成長率
  • 中東・アフリカの市場規模・前年比成長率
    • 収益の前年比成長率
    • 売上の前年比成長率

第3章 世界の噴霧式経鼻ワクチン:アプリケーション別

  • セグメント:アプリケーション別
    • 小児
    • 成人
  • 世界の売上比較:アプリケーション別
  • 世界の売上実績:アプリケーション別
  • 世界売上予測:アプリケーション別
  • 主要地域の市場規模:アプリケーション別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ

第4章 北米の噴射式経鼻ワクチン市場:国別

  • 北米市場のシェア:国別
    • 売上シェア:国別
    • 収益シェア:国別
  • 北米市場のシェア予測:国別
    • 売上シェア予測:国別
    • 収益シェア予測:国別
  • 北米の市場規模・前年比成長率:国別
    • 米国
    • カナダ

第5章 欧州の噴射式経鼻ワクチン市場:国別

  • 欧州市場のシェア:国別
    • 売上シェア:国別
    • 収益シェア:国別
  • 欧州市場のシェア予測:国別
    • 売上シェア予測:国別
    • 収益シェア予測:国別
  • 欧州の市場規模・前年比成長率:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第6章 アジア太平洋の噴射式経鼻ワクチン市場:国別

  • アジア太平洋市場のシェア:国別
    • 売上シェア:国別
    • 収益シェア:国別
  • アジア太平洋市場のシェア予測:国別
    • 売上シェア予測:国別
    • 収益シェア予測:国別
  • アジア太平洋の市場規模・前年比成長率:国別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア

第7章 南米の噴射式経鼻ワクチン市場:国別

  • 南米市場のシェア:国別
    • 売上シェア:国別
    • 収益シェア:国別
  • 南米市場のシェア予測:国別
    • 売上シェア予測:国別
    • 収益シェア予測:国別
  • 南米の市場規模・前年比成長率:国別
    • ブラジル
    • アルゼンチン

第8章 中東・アフリカの噴射式経鼻ワクチン市場:国別

  • 中東・アフリカ市場のシェア:国別
    • 売上シェア:国別
    • 収益シェア:国別
  • 中東・アフリカ市場のシェア予測:国別
    • 売上シェア予測:国別
    • 収益シェア予測:国別
  • 中東・アフリカの市場規模・前年比成長率:国別
    • 中東

第9章 企業プロファイル

  • AstraZeneca FLUMIST
  • Cipla
  • BCHT
  • Global Nasal Spray Vaccine Sales Volume Forecast by Players (2020-2026)

第10章 噴射式経鼻ワクチンの上流、機会、課題、リスク、および影響要因分析

  • 主要原材料
    • 主な原材料
    • 原材料の主要サプライヤー
  • 製造コスト構造
    • 原材料
    • 人件費
    • 製造費
  • 産業チェーン分析
  • 市場動向、機会、課題、リスクおよび影響要因分析
    • COVID-19の影響:市場動向
    • COVID-19の影響:市場成長要因
    • COVID-19の影響:市場課題
    • ポーターのファイブフォース分析
    • 噴射式経鼻ワクチンと注射ワクチン市場の成功リスク分析
  • 主要企業の製品ソリューションとサービス
  • 市場参入日

第11章 マーケティング戦略分析、ディストリビューター

  • 販売チャネル
  • ディストリビューター
  • 下流顧客

第12章 調査成果と結論

第13章 付録

図表

List of Tables and Figures

  • Table 1. Overview of the World Economic Outlook Projections 6
  • Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) 8
  • Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 9
  • Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 10
  • Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 11
  • Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 12
  • Table 7. Covid-19 Impact: Global Major Government Policy 17
  • Table 8. Global Nasal Spray Vaccine Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026 21
  • Table 9. Global Nasal Spray Vaccine Sales (K Dose) by Region (2015-2020) 21
  • Table 10. Global Nasal Spray Vaccine Sales Market Share by Region (2015-2020) 22
  • Table 11. Global Nasal Spray Vaccine Revenue (US$ Million) by Region (2015-2020) 22
  • Table 12. Global Nasal Spray Vaccine Revenue Market Share by Region (2015-2020) 22
  • Table 13. Global Nasal Spray Vaccine Sales (K Dose) by Region (2021-2026) 23
  • Table 14. Global Nasal Spray Vaccine Sales Market Share by Region (2021-2026) 23
  • Table 15. Global Nasal Spray Vaccine Revenue (US$ Million) by Region (2021-2026) 23
  • Table 16. Global Nasal Spray Vaccine Revenue Market Share by Region (2021-2026) 24
  • Table 17. Global Nasal Spray Vaccine Sales (K Dose) by Application: 2015 VS 2020 VS 2026 33
  • Table 18. Global Nasal Spray Vaccine Sales (K Dose) by Application (2015-2020) 33
  • Table 19. Global Nasal Spray Vaccine Sales Share by Application (2015-2020) 33
  • Table 20. Global Nasal Spray Vaccine Sales (K Dose) by Application (2021-2026) 33
  • Table 21. Global Nasal Spray Vaccine Sales Share by Application (2021-2026) 34
  • Table 22. North America Nasal Spray Vaccine Sales (K Dose) by Application (2015-2020) 34
  • Table 23. North America Sales Nasal Spray Vaccine Market Share by Application (2015-2020) 34
  • Table 24. Europe Nasal Spray Vaccine Sales (K Dose) by Application (2015-2020) 34
  • Table 25. Europe Sales Nasal Spray Vaccine Market Share by Application In 2019 35
  • Table 26. Asia-Pacific Nasal Spray Vaccine Sales (K Dose) by Application (2015-2020) 35
  • Table 27. Asia-Pacific Sales Nasal Spray Vaccine Market Share by Application In 2019 35
  • Table 28. South America Nasal Spray Vaccine Sales (K Dose) by Application (2015-2020) 35
  • Table 29. South America Sales Nasal Spray Vaccine Market Share by Application In 2019 35
  • Table 30. Middle East and Africa Nasal Spray Vaccine Sales (K Dose) by Application (2015-2020) 36
  • Table 31. Middle East and Africa Nasal Spray Vaccine Sales Share by Application (2015-2020) 36
  • Table 32. North America Nasal Spray Vaccine Sales (K Dose) by Country (2015-2020) 37
  • Table 33. North America Nasal Spray Vaccine Sales Market Share by Country (2015-2020) 37
  • Table 34. North America Nasal Spray Vaccine Revenue (US$ Million) by Country (2015-2020) 37
  • Table 35. North America Nasal Spray Vaccine Revenue Market Share by Country (2015-2020) 38
  • Table 36. North America Nasal Spray Vaccine Sales (K Dose) by Country (2021-2026) 38
  • Table 37. North America Nasal Spray Vaccine Sales Market Share by Country (2021-2026) 38
  • Table 38. North America Nasal Spray Vaccine Revenue (US$ Million) by Country (2021-2026) 39
  • Table 39. North America Nasal Spray Vaccine Revenue Market Share by Country (2021-2026) 39
  • Table 40. Europe Nasal Spray Vaccine Sales (K Dose) by Country (2015-2020) 42
  • Table 41. Europe Nasal Spray Vaccine Sales Market Share by Country (2015-2020) 42
  • Table 42. Europe Nasal Spray Vaccine Revenue (US$ Million) by Country (2015-2020) 42
  • Table 43. Europe Nasal Spray Vaccine Revenue Market Share by Country (2015-2020) 43
  • Table 44. Europe Nasal Spray Vaccine Sales (K Dose) by Country (2021-2026) 43
  • Table 45. Europe Nasal Spray Vaccine Sales Market Share by Country (2021-2026) 43
  • Table 46. Europe Nasal Spray Vaccine Revenue (US$ Million) by Country (2021-2026) 44
  • Table 47. Europe Nasal Spray Vaccine Revenue Market Share by Country (2021-2026) 44
  • Table 48. Asia-Pacific Nasal Spray Vaccine Sales (K Dose) by Region (2015-2020) 50
  • Table 49. Asia-Pacific Nasal Spray Vaccine Sales Market Share by Region (2015-2020) 50
  • Table 50. Asia-Pacific Nasal Spray Vaccine Revenue (US$ Million) by Region (2015-2020) 51
  • Table 51. Asia-Pacific Nasal Spray Vaccine Revenue Market Share by Region (2015-2020) 51
  • Table 52. Asia-Pacific Nasal Spray Vaccine Sales (K Dose) by Region (2021-2026) 51
  • Table 53. Asia-Pacific Nasal Spray Vaccine Sales Market Share by Region (2021-2026) 52
  • Table 54. Asia-Pacific Nasal Spray Vaccine Revenue (US$ Million) by Region (2021-2026) 52
  • Table 55. Asia-Pacific Nasal Spray Vaccine Revenue Market Share by Region (2021-2026) 52
  • Table 56. South America Nasal Spray Vaccine Sales (K Dose) by Country (2015-2020) 59
  • Table 57. South America Nasal Spray Vaccine Sales Market Share by Country (2015-2020) 59
  • Table 58. South America Nasal Spray Vaccine Revenue (US$ Million) by Country (2015-2020) 60
  • Table 59. South America Nasal Spray Vaccine Revenue Market Share by Country (2015-2020) 60
  • Table 60. South America Nasal Spray Vaccine Sales (K Dose) by Country (2021-2026) 60
  • Table 61. South America Nasal Spray Vaccine Sales Market Share by Country (2021-2026) 61
  • Table 62. South America Nasal Spray Vaccine Revenue (US$ Million) by Country (2021-2026) 61
  • Table 63. South America Nasal Spray Vaccine Revenue Market Share by Country (2021-2026) 61
  • Table 64. Middle East and Africa Nasal Spray Vaccine Sales (K Dose) by Country (2015-2020) 64
  • Table 65. Middle East and Africa Nasal Spray Vaccine Sales Market Share by Country (2015-2020) 64
  • Table 66. Middle East and Africa Nasal Spray Vaccine Revenue (US$ Million) by Country (2015-2020) 64
  • Table 67. Middle East and Africa Nasal Spray Vaccine Revenue Market Share by Country (2015-2020) 65
  • Table 68. Middle East and Africa Nasal Spray Vaccine Sales (K Dose) by Country (2021-2026) 65
  • Table 69. Middle East and Africa Nasal Spray Vaccine Sales Market Share by Country (2021-2026) 65
  • Table 70. Middle East and Africa Nasal Spray Vaccine Revenue (US$ Million) by Country (2021-2026) 66
  • Table 71. Middle East and Africa Nasal Spray Vaccine Revenue Market Share by Country (2021-2026) 66
  • Table 72. AstraZeneca FLUMIST Corporation Information 68
  • Table 73. AstraZeneca FLUMIST Description and Business Overview 69
  • Table 74. AstraZeneca FLUMIST Nasal Spray Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2020) 69
  • Table 75. AstraZeneca FLUMIST Nasal Spray Vaccine Product 70
  • Table 76. AstraZeneca FLUMIST Recent Development 70
  • Table 77. Cipla Company Details 73
  • Table 78. Cipla Nasal Spray Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2020) 74
  • Table 79. BCHT Company Details 75
  • Table 80. BCHT Nasal Spray Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2020) 77
  • Table 81. Global Nasal Spray Vaccine Sales Volume (K Dose) Forecast by Players (2020-2026) 78
  • Table 82. Key Raw Materials Lists 79
  • Table 83. Raw Materials Key Suppliers Lists 79
  • Table 84. Nasal Spray Vaccine Manufacturing Cost Structure 82
  • Table 85. The Covid-19 Impact on Nasal Spray Vaccine Assessment 83
  • Table 86. COVID-19 Impact: Nasal Spray Vaccine Market Trends 85
  • Table 87. COVID-19 Impact: Drivers 85
  • Table 88. COVID-19 Impact: Nasal Spray Vaccine Challenges 86
  • Table 89. Nasal Spray Vaccine and Injections Vaccine Compare 87
  • Table 90. Key Players Nasal Spray Vaccine Product Solution and Service 88
  • Table 91. Date of Enter into Nasal Spray Vaccine Market 88
  • Table 92. Research Programs/Design for This Report 94
  • Table 93. Key Data Information from Secondary Sources 97
  • Table 94. Key Data Information from Primary Sources 99
  • Figure 1. Nasal Spray Vaccine Product Picture 1
  • Figure 2. Global Nasal Spray Vaccine Market Size (Value), (US$ Million), 2015 VS 2020 VS 2026 2
  • Figure 3. Global Nasal Spray Vaccine Revenue (US$ Million) Status and Outlook (2015-2026) 3
  • Figure 4. Global Nasal Spray Vaccine Sales (K Dose) Status and Outlook (2015-2026) 3
  • Figure 5. Commodity Prices-Metals Price Indices 13
  • Figure 6. Commodity Prices- Precious Metal Price Indices 13
  • Figure 7. Commodity Prices- Agricultural Raw Material Price Indices 14
  • Figure 8. Commodity Prices- Food and Beverage Price Indices 14
  • Figure 9. Commodity Prices- Fertilizer Price Indices 15
  • Figure 10. Commodity Prices- Energy Price Indices 16
  • Figure 11. G20+: Economic Policy Responses to COVID-19 16
  • Figure 12. North America Nasal Spray Vaccine Revenue (US$ Million) and Growth Rate (2015-2026) 24
  • Figure 13. North America Nasal Spray Vaccine Sales YoY Growth (2015-2026) (K Dose) 25
  • Figure 14. Asia-Pacific Nasal Spray Vaccine Revenue (US$ Million) and Growth Rate (2015-2026) 25
  • Figure 15. Asia-Pacific Nasal Spray Vaccine Sales YoY Growth (2015-2026) (K Dose) 26
  • Figure 16. Europe Nasal Spray Vaccine Revenue (US$ Million) and Growth Rate (2015-2026) 26
  • Figure 17. Europe Nasal Spray Vaccine Sales YoY Growth (2015-2026) (K Dose) 27
  • Figure 18. South America Nasal Spray Vaccine Revenue (US$ Million) and Growth Rate (2015-2026) 28
  • Figure 19. South America Nasal Spray Vaccine Sales YoY Growth (2015-2026) (K Dose) 29
  • Figure 20. Middle East and Africa Nasal Spray Vaccine Revenue (US$ Million) and Growth Rate (2015-2026) 30
  • Figure 21. Middle East and Africa Nasal Spray Vaccine Sales YoY Growth (2015-2026) (K Dose) 31
  • Figure 22. Child Examples 32
  • Figure 23. Adult Examples 32
  • Figure 24. United States Nasal Spray Vaccine Sales (K Dose) (2015-2026) 40
  • Figure 25. United States Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 40
  • Figure 26. Canada Nasal Spray Vaccine Sales (K Dose) (2015-2026) 41
  • Figure 27. Canada Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 41
  • Figure 28. Germany Nasal Spray Vaccine Sales (K Dose) (2015-2026) 45
  • Figure 29. Germany Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 45
  • Figure 30. France Nasal Spray Vaccine Sales (K Dose) (2015-2026) 46
  • Figure 31. France Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 46
  • Figure 32. U.K. Nasal Spray Vaccine Sales (K Dose) (2015-2026) 47
  • Figure 33. U.K. Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 47
  • Figure 34. Italy Nasal Spray Vaccine Sales (K Dose) (2015-2026) 48
  • Figure 35. Italy Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 48
  • Figure 36. Russia Nasal Spray Vaccine Sales (K Dose) (2015-2026) 49
  • Figure 37. Russia Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 49
  • Figure 38. China Nasal Spray Vaccine Sales (K Dose) (2015-2026) 53
  • Figure 39. China Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 54
  • Figure 40. Japan Nasal Spray Vaccine Sales (K Dose) (2015-2026) 54
  • Figure 41. Japan Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 55
  • Figure 42. South Korea Nasal Spray Vaccine Sales (K Dose) (2015-2026) 55
  • Figure 43. South Korea Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 56
  • Figure 44. India Nasal Spray Vaccine Sales (K Dose) (2015-2026) 56
  • Figure 45. India Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 57
  • Figure 46. Australia Nasal Spray Vaccine Sales (K Dose) (2015-2026) 57
  • Figure 47. Australia Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 58
  • Figure 48. Brazil Nasal Spray Vaccine Sales (K Dose) (2015-2026) 62
  • Figure 49. Brazil Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 62
  • Figure 50. Argentina Nasal Spray Vaccine Sales (K Dose) (2015-2026) 63
  • Figure 51. Argentina Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 63
  • Figure 52. Middle East Nasal Spray Vaccine Sales (K Dose) (2015-2026) 67
  • Figure 53. Middle East Nasal Spray Vaccine Revenue (US$ Million) (2015-2026) 67
  • Figure 54. Vaccination Device for Intranasal Route 72
  • Figure 55. Cipla Nasal Spray Vaccine Product 74
  • Figure 56. Vaccination Device for Intranasal Route 75
  • Figure 57. BCHT Nasal Spray Vaccine Product 77
  • Figure 58. Vaccination Device for Intranasal Route 78
  • Figure 59. Nasal Spray Vaccine Industrial Chain Analysis 83
  • Figure 60. Porter's Five Forces Analysis 87
  • Figure 61. Channels of Distribution 90
  • Figure 62. Distributors Profiles 91
  • Figure 63. Bottom-up and Top-down Approaches for This Report 96
  • Figure 64. Data Triangulation 97
  • Figure 65. Key Executives Interviewed 99
目次

Market Analysis and Insights: Global Nasal Spray Vaccine Market

The global Nasal Spray Vaccine market was valued at US$ 114.96 million in 2019 and it is expected to reach US$ 198.26 million by the end of 2026, growing at a CAGR of 7.66% during 2020-2026.

Global Nasal Spray Vaccine Scope and Market Size

The global Nasal Spray Vaccine market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Nasal Spray Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nasal Spray Vaccine market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the Nasal Spray Vaccine industry.

By Company

  • AstraZeneca FLUMIST
  • Cipla
  • BCHT

Segment by Application

Child

  • Adult

By Region

North America

  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Southeast Asia
      • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Latin America
  • Brazil
  • Colombia
  • Argentina
  • Middle East & Africa
  • Middle East
  • Africa

TABLE OF CONTENTS

1 NASAL SPRAY VACCINE MARKET OVERVIEW 1

  • 1.1 Nasal Spray Vaccine Product Overview 1
  • 1.2 Difference between the Flu Shot vs. FluMist 3
    • 1.2.1 Price 3
    • 1.2.2 Nasal Congestion 4
    • 1.2.3 Shot vs. Nasal Mists 4
    • 1.2.4 Inactive vs. Live 4
    • 1.2.5 Slight Pain vs. No Pain 4
    • 1.2.6 Less Restriction vs. More Restrictions 4
  • 1.3 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 4
    • 1.3.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 4
    • 1.3.2 Covid-19 Impact: Commodity Prices Indices 12
    • 1.3.3 Covid-19 Impact: Global Major Government Policy 16

2 GLOBAL NASAL SPRAY VACCINE STATUS AND OUTLOOK BY REGION (2015-2026) 21

  • 2.1 Global Nasal Spray Vaccine Market Size and CAGR by Region: 2015 VS 2020 VS 2026 21
  • 2.2 Global Nasal Spray Vaccine Market Size Market Share by Region (2015-2020) 21
    • 2.2.1 Global Nasal Spray Vaccine Sales Market Share by Region (2015-2020) 21
    • 2.2.2 Global Nasal Spray Vaccine Revenue Market Share by Region (2015-2020) 22
  • 2.3 Global Nasal Spray Vaccine Market Size Market Share by Region (2021-2026) 23
    • 2.3.1 Global Nasal Spray Vaccine Sales Market Share by Region (2021-2026) 23
    • 2.3.2 Global Nasal Spray Vaccine Revenue Market Share by Region (2021-2026) 23
  • 2.4 North America Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 24
    • 2.4.1 North America Nasal Spray Vaccine Revenue YoY Growth (2015-2026) 24
    • 2.4.2 North America Nasal Spray Vaccine Sales YoY Growth (2015-2026) 25
  • 2.5 Asia-Pacific Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 25
    • 2.5.1 Asia-Pacific Nasal Spray Vaccine Revenue YoY Growth (2015-2026) 25
    • 2.5.2 Asia-Pacific Nasal Spray Vaccine Sales YoY Growth (2015-2026) 26
  • 2.6 Europe Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 26
    • 2.6.1 Europe Nasal Spray Vaccine Revenue YoY Growth (2015-2026) 26
    • 2.6.2 Europe Nasal Spray Vaccine Sales YoY Growth (2015-2026) 27
  • 2.7 South America Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 28
    • 2.7.1 South America Nasal Spray Vaccine Revenue YoY Growth (2015-2026) 28
    • 2.7.2 South America Nasal Spray Vaccine Sales YoY Growth (2015-2026) 29
  • 2.8 Middle East and Africa Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 30
    • 2.8.1 Middle East and Africa Nasal Spray Vaccine Revenue YoY Growth (2015-2026) 30
    • 2.8.2 Middle East and Africa Nasal Spray Vaccine Sales YoY Growth (2015-2026) 31

3 GLOBAL NASAL SPRAY VACCINE BY APPLICATION 32

  • 3.1 Nasal Spray Vaccine Segment by Application 32
    • 3.1.1 Child 32
    • 3.1.2 Adult 32
  • 3.2 Global Nasal Spray Vaccine Sales by Application: 2015 VS 2020 VS 2026 33
  • 3.3 Global Nasal Spray Vaccine Historic Sales by Application (2015-2020) 33
  • 3.4 Global Nasal Spray Vaccine Forecasted Sales by Application (2021-2026) 33
  • 3.5 Key Regions Nasal Spray Vaccine Market Size by Application 34
    • 3.5.1 North America Nasal Spray Vaccine by Application 34
    • 3.5.2 Europe Nasal Spray Vaccine by Application 34
    • 3.5.3 Asia-Pacific Nasal Spray Vaccine by Application 35
    • 3.5.4 South America Nasal Spray Vaccine by Application 35
    • 3.5.5 Middle East and Africa Nasal Spray Vaccine by Application 36

4 NORTH AMERICA NASAL SPRAY VACCINE MARKET SIZE BY COUNTRY (2015-2026) 37

  • 4.1 North America Nasal Spray Vaccine Market Size Market Share by Country (2015-2020) 37
    • 4.1.1 North America Nasal Spray Vaccine Sales Market Share by Country (2015-2020) 37
    • 4.1.2 North America Nasal Spray Vaccine Revenue Market Share by Country (2015-2020) 37
  • 4.2 North America Nasal Spray Vaccine Market Size Market Share by Country (2021-2026) 38
    • 4.2.1 North America Nasal Spray Vaccine Sales Market Share by Country (2021-2026) 38
    • 4.2.2 North America Nasal Spray Vaccine Revenue Market Share by Country (2021-2026) 39
  • 4.3 North America Market Size YoY Growth by Country 40
    • 4.3.1 United States Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 40
    • 4.3.2 Canada Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 41

5 EUROPE NASAL SPRAY VACCINE MARKET SIZE BY COUNTRY (2015-2026) 42

  • 5.1 Europe Nasal Spray Vaccine Market Size Market Share by Country (2015-2020) 42
    • 5.1.1 Europe Nasal Spray Vaccine Sales Market Share by Country (2015-2020) 42
    • 5.1.2 Europe Nasal Spray Vaccine Revenue Market Share by Country (2015-2020) 42
  • 5.2 Europe Nasal Spray Vaccine Market Size Market Share by Country (2021-2026) 43
    • 5.2.1 Europe Nasal Spray Vaccine Sales Market Share by Country (2021-2026) 43
    • 5.2.2 Europe Nasal Spray Vaccine Revenue Market Share by Country (2021-2026) 44
  • 5.3 Europe Market Size YoY Growth by Country 45
    • 5.3.1 Germany Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 45
    • 5.3.2 France Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 46
    • 5.3.3 U.K. Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 47
    • 5.3.4 Italy Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 48
    • 5.3.5 Russia Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 49

6 ASIA-PACIFIC NASAL SPRAY VACCINE MARKET SIZE BY REGION (2015-2026) 50

  • 6.1 Asia-Pacific Nasal Spray Vaccine Market Size Market Share by Region (2015-2020) 50
    • 6.1.1 Asia-Pacific Nasal Spray Vaccine Sales Market Share by Region (2015-2020) 50
    • 6.1.2 Asia-Pacific Nasal Spray Vaccine Revenue Market Share by Region (2015-2020) 51
  • 6.2 Asia-Pacific Nasal Spray Vaccine Market Size Market Share by Region (2021-2026) 51
    • 6.2.1 Asia-Pacific Nasal Spray Vaccine Sales Market Share by Region (2021-2026) 51
    • 6.2.2 Asia-Pacific Nasal Spray Vaccine Revenue Market Share by Region (2021-2026) 52
  • 6.3 Asia-Pacific Market Size YoY Growth by Region 53
    • 6.3.1 China Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 53
    • 6.3.2 Japan Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 54
    • 6.3.3 South Korea Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 55
    • 6.3.4 India Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 56
    • 6.3.5 Australia Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 57

7 SOUTH AMERICA NASAL SPRAY VACCINE MARKET SIZE BY COUNTRY (2015-2026) 59

  • 7.1 South America Nasal Spray Vaccine Market Size Market Share by Country (2015-2020) 59
    • 7.1.1 South America Nasal Spray Vaccine Sales Market Share by Country (2015-2020) 59
    • 7.1.2 South America Nasal Spray Vaccine Revenue Market Share by Country (2015-2020) 60
  • 7.2 South America Nasal Spray Vaccine Market Size Market Share by Country (2021-2026) 60
    • 7.2.1 South America Nasal Spray Vaccine Sales Market Share by Country (2021-2026) 60
    • 7.2.2 South America Nasal Spray Vaccine Revenue Market Share by Country (2021-2026) 61
  • 7.3 South America Market Size YoY Growth by Country 62
    • 7.3.1 Brazil Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 62
    • 7.3.2 Argentina Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 63

8 MIDDLE EAST AND AFRICA NASAL SPRAY VACCINE MARKET SIZE BY COUNTRY (2015-2026) 64

  • 8.1 Middle East and Africa Nasal Spray Vaccine Market Size Market Share by Country (2015-2020) 64
    • 8.1.1 Middle East and Africa Nasal Spray Vaccine Sales Market Share by Country (2015-2020) 64
    • 8.1.2 Middle East and Africa Nasal Spray Vaccine Revenue Market Share by Country (2015-2020) 64
  • 8.2 Middle East and Africa Nasal Spray Vaccine Market Size Market Share by Country (2021-2026) 65
    • 8.2.1 Middle East and Africa Nasal Spray Vaccine Sales Market Share by Country (2021-2026) 65
    • 8.2.2 Middle East and Africa Nasal Spray Vaccine Revenue Market Share by Country (2021-2026) 66
  • 8.3 Middle East and Africa Market Size YoY Growth by Country 67
    • 8.3.1 Middle East Nasal Spray Vaccine Market Size YoY Growth (2015-2026) 67

9 COMPANY PROFILES AND KEY FIGURES IN NASAL SPRAY VACCINE BUSINESS 68

  • 9.1 AstraZeneca FLUMIST 68
    • 9.1.1 AstraZeneca FLUMIST Corporation Information 68
    • 9.1.2 AstraZeneca FLUMIST Description, Business Overview and Total Revenue 69
    • 9.1.3 AstraZeneca FLUMIST Nasal Spray Vaccine Sales, Revenue and Gross Margin (2019-2020) 69
    • 9.1.4 AstraZeneca FLUMIST Nasal Spray Vaccine Products Offered 70
    • 9.1.5 AstraZeneca FLUMIST Recent Development 70
    • 9.1.6 Vaccination Device for Intranasal Route 72
  • 9.2 Cipla 73
    • 9.2.1 Cipla Company Details 73
    • 9.2.2 Cipla Nasal Spray Vaccine Introduction 74
    • 9.2.3 Cipla Nasal Spray Vaccine Sales, Revenue and Gross Margin (2019-2020) 74
    • 9.2.4 Vaccination Device for Intranasal Route 75
  • 9.3 BCHT 75
    • 9.3.1 BCHT Company Details 75
    • 9.3.2 BCHT Nasal Spray Vaccine Introduction 77
    • 9.3.3 BCHT Nasal Spray Vaccine Sales, Revenue and Gross Margin (2019-2020) 77
    • 9.3.4 Vaccination Device for Intranasal Route 78
  • 9.4 Global Nasal Spray Vaccine Sales Volume Forecast by Players (2020-2026) 78

10 NASAL SPRAY VACCINE UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 79

  • 10.1 Nasal Spray Vaccine Key Raw Materials 79
    • 10.1.1 Key Raw Materials 79
    • 10.1.2 Raw Materials Key Suppliers 79
  • 10.2 Manufacturing Cost Structure 82
    • 10.2.1 Raw Materials 82
    • 10.2.2 Labor Cost 82
    • 10.2.3 Manufacturing Expenses 82
  • 10.3 Nasal Spray Vaccine Industrial Chain Analysis 83
  • 10.4 Market Trend, Opportunities, Challenges, Risks and Influences Factors Analysis 83
    • 10.4.1 COVID-19 Impact: Nasal Spray Vaccine Market Trends 85
    • 10.4.2 COVID-19 Impact: Market Drivers 85
    • 10.4.3 COVID-19 Impact: Nasal Spray Vaccine Market Challenges 86
    • 10.4.4 Porter's Five Forces Analysis 86
    • 10.4.5 Nasal Spray Vaccine and Injections Vaccine Market Success Risk Analysis 87
      • 10.4.5.1 Nasal Spray Vaccine and Injections Vaccine Compare 87
      • 10.4.5.2 Nasal Spray Vaccine Development Restricting Factors Analysis 88
  • 10.5 Key Players Nasal Spray Vaccine Product Solution and Service 88
  • 10.6 Date of Enter into Nasal Spray Vaccine Market 88

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 89

  • 11.1 Sales Channel 89
  • 11.2 Distributors 91
  • 11.3 Downstream Customers 91

12 RESEARCH FINDINGS AND CONCLUSION 93

13 APPENDIX 94

  • 13.1 Research Methodology 94
    • 13.1.1 Methodology/Research Approach 94
      • 13.1.1.1 Research Programs/Design 94
      • 13.1.1.2 Market Size Estimation 95
      • 13.1.1.3 Market Breakdown and Data Triangulation 96
    • 13.1.2 Data Source 97
      • 13.1.2.1 Secondary Sources 97
      • 13.1.2.2 Primary Sources 98
  • 13.2 Author Details 100
  • 13.3 Disclaimer 100